Studies have shown that the most important feature that distinguishes SEPT9 from currently used glycoproteins such as CEA, CA199, CA242, CA72-4, and CA125 is that it is the most sensitive diagnostic biomarker that can be used alone for the early diagnosis of CRC [20,25]. Here, CEACAM5 is linked to colorectal carcinoma.